Of these, PTPN18 overexpression is particularly noteworthy as this gene has been shown to promote glioblastomas by decreasing CD8+ T cell infiltration to enhance immune suppression, making the identification of immunotherapy targets for this gene crucial for halting tumor growth [34]. This evidence concerns the gene CD8A and glioblastoma.